These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22546407)

  • 1. Re: Liao et al.: Serum C-reactive protein levels are associated with residual urgency symptoms in patients with benign prostatic hyperplasia after medical treatment. (Urology 2011;78:1373-1379).
    Mandal S; Patil SB; Goel A
    Urology; 2012 May; 79(5):1192; author reply 1192-3. PubMed ID: 22546407
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum C-reactive protein levels are associated with residual urgency symptoms in patients with benign prostatic hyperplasia after medical treatment.
    Liao CH; Chung SD; Kuo HC
    Urology; 2011 Dec; 78(6):1373-8. PubMed ID: 21962879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial comment.
    Scarpa RM; Cracco CM
    Urology; 2011 Dec; 78(6):1378-9; author reply 1379. PubMed ID: 22137707
    [No Abstract]   [Full Text] [Related]  

  • 4. Invited commentary: Lower urinary tract symptoms and inflammation--weighing the evidence.
    Freedland SJ; Aronson WJ
    Am J Epidemiol; 2009 Jun; 169(11):1291-3; discussion 1294-5. PubMed ID: 19395692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between lower urinary tract symptoms and serum levels of sex hormones in men with symptomatic benign prostatic hyperplasia.
    Favilla V; Cimino S; Castelli T; Madonia M; Barbagallo I; Morgia G
    BJU Int; 2010 Dec; 106(11):1700-3. PubMed ID: 20575982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Hellstrom WJG, et al.: Ejaculatory dysfunction and its association with lower urinary tract symptoms of benign prostatic hyperplasia (BPH) and BPH treatment. (Urology 2009;74:15-21).
    Schmid HP; Böhlen D
    Urology; 2009 Dec; 74(6):1377; author reply 1377-8. PubMed ID: 19962542
    [No Abstract]   [Full Text] [Related]  

  • 7. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry.
    Wei JT; Miner MM; Steers WD; Rosen RC; Seftel AD; Pasta DJ; Carman WJ; Roehrborn CG;
    J Urol; 2011 Sep; 186(3):971-6. PubMed ID: 21791352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling old men.
    Cohen PG
    BJU Int; 2010 Jun; 105(11):1607. PubMed ID: 20553460
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Burke et al.: systematic review and meta-analysis of transurethral resection of the prostate versus minimally invasive procedures for the treatment of benign prostatic obstruction (Urology 2010;75: 1015-1022).
    Mamoulakis C; de la Rosette JJ; Ubbink DT
    Urology; 2010 May; 75(5):1235-6; author reply 1236-7. PubMed ID: 20451750
    [No Abstract]   [Full Text] [Related]  

  • 10. The relationship between lower urinary tract symptoms/benign prostatic hyperplasia and the number of components of metabolic syndrome.
    Park YW; Kim SB; Kwon H; Kang HC; Cho K; Lee KI; Kim YJ; Lee JH
    Urology; 2013 Sep; 82(3):674-9. PubMed ID: 23850334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling older men.
    Trifiro MD; Parsons JK; Palazzi-Churas K; Bergstrom J; Lakin C; Barrett-Connor E
    BJU Int; 2010 Jun; 105(11):1554-9. PubMed ID: 20002438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Christian G. Stief, Hartmut Porst, Dieter Neuser, et al. A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol 2008;53:1236-44.
    Gacci M; Carini M; Maggi M
    Eur Urol; 2009 Jan; 55(1):e25-6. PubMed ID: 18486304
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Serum C-reactive protein levels are associated with residual urgency symptoms in patients with benign prostatic hyperplasia after medical treatment.
    Schaeffer EM
    J Urol; 2012 Sep; 188(3):835-6. PubMed ID: 22883769
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical significance of prostatic-urethral angulation on the treatment outcome of patients with symptomatic benign prostatic hyperplasia treated with tamsulosin hydrochloride.
    El-Tatawy H; Gameel T; El-enen MA; Hagras A; Mousa A; El-Bahnasy AH; Raheem AA; Abu-dewan K
    Arch Ital Urol Androl; 2015 Sep; 87(3):238-42. PubMed ID: 26428648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol consumption is associated with a decreased risk of benign prostatic hyperplasia.
    Parsons JK; Im R
    J Urol; 2009 Oct; 182(4):1463-8. PubMed ID: 19683313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of phytotherapy on utility scores for 5 benign prostatic hyperplasia/lower urinary tract symptoms health states.
    Dedhia RC; Calhoun E; McVary KT
    J Urol; 2008 Jan; 179(1):220-5. PubMed ID: 18001791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoadiponectinemia, elevated iron and high-sensitivity C-reactive protein levels and their relation with prostate size in benign prostatic hyperplasia.
    Nandeesha H; Eldhose A; Dorairajan LN; Anandhi B
    Andrologia; 2017 Sep; 49(7):. PubMed ID: 27658341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correspondence re: B-L. Adam et al., Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res., 62: 3609-3614, 2002.
    Stattin P; Hakama M
    Cancer Res; 2003 May; 63(10):2701; author reply 2701-2. PubMed ID: 12750300
    [No Abstract]   [Full Text] [Related]  

  • 19. Relevance of benign prostatic hyperplasia and associated conditions for urologists, health care systems, and society.
    Oelke M; Gravas S
    World J Urol; 2010 Feb; 28(1):1-2. PubMed ID: 20076962
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic kidney disease among men with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Hong SK; Lee ST; Jeong SJ; Byun SS; Hong YK; Park DS; Hong JY; Son JH; Kim C; Jang SH; Lee SE
    BJU Int; 2010 May; 105(10):1424-8. PubMed ID: 19874305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.